What Bajaj Finserv Healthcare Fund bought and sold in September 2026
This compares the fund's portfolio at the end of September 2026 with the month before. Both come from the monthly portfolio statement of Bajaj Finserv Mutual Fund.
Bajaj Finserv Healthcare Fund Stocks Bought and Sold
All changes are between August 2026 and September 2026
More
| Divi's Laboratories Limited | Reduced | −6.0% | 9.75% |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Added | +19.1% | 8.96% |
| Piramal Pharma Limited | Reduced | −2.0% | 6.36% |
| Laurus Labs Limited | Added | +60.0% | 3.91% |
| Alkem Laboratories Limited | New | New | 2.96% |
| Turtlemint Fintech Solutions Limited | Sold out | −100% | was 0.92% |
| MTAR Technologies Limited | Sold out | −100% | was 0.26% |
No stocks in this group for September 2026.
A change is counted by the number of shares the fund holds, not by price. A stock can become a smaller part of the fund in a month when the fund bought more of it, if its price fell. Debt papers are left out.
Frequently Asked Questions
Which new stocks did Bajaj Finserv Healthcare Fund buy in September 2026?
It bought 1 new stock: Alkem Laboratories Limited (2.96%). Each figure is the stock's share of the fund at the end of September 2026.
Which stocks did Bajaj Finserv Healthcare Fund sell completely in September 2026?
It sold all its shares in Turtlemint Fintech Solutions Limited (0.92%) and MTAR Technologies Limited (0.26%). Each figure is the stock's share of the fund at the end of August 2026.
Which stocks did Bajaj Finserv Healthcare Fund buy more of in September 2026?
The largest increases in shares held were Laurus Labs Limited (+60.0%) and Sun Pharmaceutical Industries Limited (+19.1%).
Which stocks did Bajaj Finserv Healthcare Fund sell part of in September 2026?
The largest cuts in shares held were Divi's Laboratories Limited (−6.0%) and Piramal Pharma Limited (−2.0%).
How are these changes worked out?
WealthGamma compares the number of shares Bajaj Finserv Healthcare Fund held on 30-09-2026 with 31-08-2026. Both figures come from the monthly portfolio statement of Bajaj Finserv Mutual Fund. A change in share price alone does not count as buying or selling.
See NAV, expense ratio and full holdings of Bajaj Finserv Healthcare Fund
This page is information, not investment advice. Mutual fund investments are subject to market risks; read all scheme related documents carefully. Past returns do not promise future returns. Figures come from AMFI, NSE, BSE and each fund house's own documents.